Skip to main content

Table 1 Sample characterization

From: Comparison of clinical outcomes in patients undergoing mitral valve replacement with mechanical or biological substitutes: a 20 years cohort

Variable

Sample (n = 352)

Mechanical valve (n = 247)

Biological valve (n = 105)

p

Mean age ± SD

52.3 ± 13.4

50.8 ± 12.5

55.8 ± 14.9

0.003

Age group - n (%)

    

≤ 50 years

161 (45.7)

118 (47.8)

43 (41.0)

< 0.001

51 - 60 years

99 (28.1)

77 (31.2)*

22 (21.0)

61 - 70 years

58 (16.5)

38 (15.4)

20 (19.0)

≥ 71 years

34 (9.7)

14 (5.7)

20 (19.0)*

Gender - n (%)

    

Male

165 (46.9)

116 (47.0)

49 (46.7)

1.000

Female

187 (53.1)

131 (53.0)

56 (53.3)

BMI (Kg/m2) - Mean ± SD

24.4 ± 4.3

24.8 ± 4.5

23.4 ± 3.8

0.003

Obesity** - n (%)

33 (9.4)

27 (10.9)

6 (5.7)

0.181

Morbid obesity*** - n (%)

1 (0.3)

1 (0.4)

0 (0.0)

1.000

Functional class (NYHA) - n (%)

    

I-II

203 (57.7)

143 (57.9)

60 (57.1)

0.990

III-IV

149 (42.3)

104 (42.1)

45 (42.9)

Pathology – n (%)

   

0.719

Failure

155 (44.0)

104 (42.1)

51 (48.6)

Stenosis

83 (23.6)

61 (24.7)

22 (21.0)

DI with predominant stenosis

84 (23.9)

60 (24.3)

24 (22.9)

DI with predominant failure

30 (8.5)

22 (8.9)

8 (7.6)

Rhythm ECG – n (%)

    

Sinus

147 (42.0)

114 (46.3)*

33 (31.7)

 

Atrial fibrillation

198 (56.6)

129 (52.4)

69 (66.3)*

0.039

Others

5 (1.4)

3 (1.2)

2 (1.9)

 

Chronic atrial fibrillation - n (%)

169 (48.0)

112 (45.3)

57 (54.3)

0.156

Diabetes mellitus - n (%)

25 (7.1)

18 (7.3)

7 (6.7)

1.000

COPD - n (%)

56 (15.9)

39 (15.8)

17 (16.2)

1.000

Stroke - n (%)

24 (6.8)

17 (6.9)

7 (6.7)

1.000

SAH - n (%)

144 (40.9)

105 (42.5)

39 (37.1)

0.413

Creatinine > 2 mg/dl – n (%)

17 (4.8)

9 (3.6)

8 (7.6)

0.187

Dialysis - n (%)

3 (0.9)

1 (0.4)

2 (1.9)

0.213

Emergency surgery - n (%)

22 (6.3)

10 (4.0)

12 (11.4)

0.017

Endocarditis - n (%)

36 (10.2)

22 (8.9)

14 (13.3)

0.288

Rheumatic fever - n (%)

153 (43.5)

112 (45.3)

41 (39.0)

0.331

  1. SD, standard deviation; BMI, body mass index; NYHA, New York Heart Association class; DI, double injury, ECG, electrocardiogram; COPD, chronic obstructive pulmonary disease; SAH, systemic arterial hypertension.
  2. *Statistically significant association by the adjusted residuals test at 5% significance.
  3. **BMI ≥ 30 kg/m2; ***BMI ≥ 40 kg/m2.